115 related articles for article (PubMed ID: 139705)
1. Localization and distribution of fibrinolysis inhibition in the walls of human arteries and veins.
Hegt VN
Thromb Res; 1977 Jan; 10(1):121-33. PubMed ID: 139705
[No Abstract] [Full Text] [Related]
2. Some fibrinolytic properties of the human arteries and veins walls.
Donner L; Vodáková L
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(4):451-9. PubMed ID: 2431965
[TBL] [Abstract][Full Text] [Related]
3. Relations between activation and inhibition of fibrinolysis in the walls of human arteries and veins.
Hegt VN
Thromb Haemost; 1977 Aug; 38(2):407-19. PubMed ID: 579485
[TBL] [Abstract][Full Text] [Related]
4. Alpha 2-plasmin inhibitor deficiency.
Lipinski B; Gurewich V
Lancet; 1979 Feb; 1(8111):329. PubMed ID: 84984
[No Abstract] [Full Text] [Related]
5. [Inhibition by ethanol and acetaldehyde the plasmin activity and plasminogen activation induced by urokinase and streptokinase].
Roszkowska-Jakimiec W; Jurkowski J; Ostrowska H; Worowski K
Rocz Akad Med Bialymst (1989); 1988-1989; 33-34():53-66. PubMed ID: 2979011
[TBL] [Abstract][Full Text] [Related]
6. Spectrophotometrical determination of plasminogen and plasmin inhibitors in human plasma using fibrin suspension as a substrate.
Saito Y; Kanai S; Takabayashi K; Inada Y
Thromb Res; 1980 Nov; 20(3):307-13. PubMed ID: 6451951
[No Abstract] [Full Text] [Related]
7. Substrate composition and the effect of epsilon-aminocaproic acid on tissue plasminogen activator and urokinase-induced fibrinolysis.
Thorsen S; Astrup T
Thromb Diath Haemorrh; 1974 Dec; 32(2-3):306-24. PubMed ID: 4281113
[No Abstract] [Full Text] [Related]
8. Inhibitor of plasminogen activator in human arterial wall. I. Histochemical study.
Okamura T; Nanno S; Sueishi K; Tanaka K
Acta Pathol Jpn; 1984 Jul; 34(4):743-7. PubMed ID: 6237546
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical localisation of tissue plasminogen activator and urokinase in the vessel wall.
Larsson A; Astedt B
J Clin Pathol; 1985 Feb; 38(2):140-5. PubMed ID: 3881480
[TBL] [Abstract][Full Text] [Related]
10. Tissue plasminogen activator (tPA) inhibits plasmin degradation of fibrin. A mechanism that slows tPA-mediated fibrinolysis but does not require alpha 2-antiplasmin or leakage of intrinsic plasminogen.
Wu JH; Diamond SL
J Clin Invest; 1995 Jun; 95(6):2483-90. PubMed ID: 7769094
[TBL] [Abstract][Full Text] [Related]
11. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
Glas-Greenwalt P; Kant KS; Allen C; Pollak VE
J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
[TBL] [Abstract][Full Text] [Related]
12. Urokinase-induced fibrin clot lysis and its inhibition by plasma.
Carlin G
Ups J Med Sci; 1980; 85(1):29-33. PubMed ID: 6446181
[TBL] [Abstract][Full Text] [Related]
13. Proceedings: Influence of plasmin inhibitors on differentiating digestion between fibrinogenolysis and fibrinolysis.
Abe T; Kazama M
Thromb Diath Haemorrh; 1975 Nov; 34(2):584. PubMed ID: 53895
[No Abstract] [Full Text] [Related]
14. The structure basis of the poor fibrin specificity of urokinase (II)--The inhibition of urokinase A chain 149-157 on the fibrin stimulated activation of plasminogen by tissue type plasminogen activator.
Song A; Liu JN; Yu RR; Cui DF; Zhou TM; Cui HR; Zhu DX
Sci China B; 1992 Aug; 35(8):966-73. PubMed ID: 1338753
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of fibrinolysis in the vitreous body.
Pandolfi M
Bibl Anat; 1979; (18):292-7. PubMed ID: 159041
[No Abstract] [Full Text] [Related]
16. The inhibitory effect of plasma inhibitor on plasmin activated with streptokinase or urokinase.
Sumi H; Takada Y; Takada A
Nihon Seirigaku Zasshi; 1977; 39(5):112-4. PubMed ID: 72149
[No Abstract] [Full Text] [Related]
17. Coronary thrombolysis: pharmacological considerations with emphasis on tissue-type plasminogen activator (t-PA).
Fox KA; Bergmann SR; Sobel BE
Biochem Pharmacol; 1984 Jun; 33(12):1831-8. PubMed ID: 6233982
[No Abstract] [Full Text] [Related]
18. Effects of kringles derived from human plasminogen on fibrinolysis in vitro.
Sugiyama N; Iwamoto M; Abiko Y
Thromb Res; 1987 Aug; 47(4):459-68. PubMed ID: 2821651
[TBL] [Abstract][Full Text] [Related]
19. Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained.
Pannell R; Black J; Gurewich V
J Clin Invest; 1988 Mar; 81(3):853-9. PubMed ID: 2963831
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of plasminogen activator associated with chronic granulomatous inflammation.
Goldstein SM; Izaki S; Epstein WL
Thromb Res; 1979; 16(5-6):727-35. PubMed ID: 160627
[No Abstract] [Full Text] [Related]
[Next] [New Search]
